Caleb Lareau is a Founding Scientist and leads the Platform Technologies group at Cartography Biosciences, focusing on the development and application of new methods for accelerating next-generation antigen discovery. Caleb completed his graduate studies at Harvard Medical School and more recently is a Stanford Science Fellow and Scholar at the Parker Institute for Cancer Immunotherapy. Whenever taking a video call from home, you can typically find Caleb struggling to keep his two cats (Boo and Nala) out of the frame.
Caleb Lareau, Ph.D.
